• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Updates, 15-08-2025: Press Release

    15-08-2025 | 09:28 pm

    Alembic Pharma secured USFDA final approval for Tretinoin Cream USP, 0.025%, for acne vulgaris. This drug targets a US$ 94 million market, enhancing Alembic's US product offerings.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited